Vistin Pharma ASA: Mandatory notification of trade

Magnus Tolleshaug, Chief Executive Officer in Vistin Pharma ASA, and a primary insider, has on 20'th of February 2026 purchased 30.000 shares in Vistin Pharma ASA at an average price of NOK 21,10 per share. Following this purchase Magnus Tolleshaug holds 105.000 shares in Vistin Pharma ASA.

Attachment

• Notification of trade_skjema - Magnus Tolleshaug

You May Also Be Interested In

• New Technologies and Achievements Make Concentrated Debuts, Highlighting CIFTIS as a Platform for Innovation
• Bekaert: Update on the Share Buyback Program and the Liquidity Agreement
• Renk Group AG: Release according to Article 40 (1) of the WpHG (the German Securities Trading Act) with the objective of Europe-wide distribution